We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current VLON market cap is 1.3M. The company's latest EPS is USD -4.0163 and P/E is -0.10.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.35M | -4.57M | -2.44M | -2.03M | -1.9M |
| Net Income | -2.4M | -6.5M | -2.14M | -2M | -1.89M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 100k | 0 | 0 | 0 |
| Operating Income | -3.15M | -4.79M | -9.26M | -6.93M | -11.39M |
| Net Income | -3.46M | -4.82M | -9.3M | -7.02M | -13.04M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.1M | 5.64M | 4.4M | 2.96M | 4.59M |
| Total Liabilities | 2.07M | 1.6M | 2.18M | 2.7M | 1.79M |
| Total Equity | 31k | 4.04M | 2.23M | 259k | 2.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.28M | 955k | 8.34M | 4.15M | 2.96M |
| Total Liabilities | 1.06M | 2.41M | 2.52M | 1.81M | 2.7M |
| Total Equity | 3.21M | -1.45M | 5.82M | 2.34M | 259k |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.12M | -2.12M | -3.43M | -8.99M | -2.2M |
| Investing | N/A | -8k | -8k | -8k | N/A |
| Financing | N/A | 6.92M | 6.92M | 10.8M | 4.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.88M | -3.71M | -8.31M | -7.14M | -8.99M |
| Investing | N/A | -2k | -3.84M | 3.78M | -8k |
| Financing | 6.09M | -4k | 15.75M | 3.43M | 10.8M |
| Market Cap | 1.3M |
| Price to Earnings Ratio | -0.10 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.72 |
| Price to Book Ratio | 5.01 |
| Dividend Yield | - |
| Shares Outstanding | 3.25M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (2.38%) |
| Company Name | Vallon Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://vallonpharmaceutical |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
